Application 209672
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE | TABLET;ORAL | EQ 450MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69097-277 | Valganciclovir | Valganciclovir | Cipla USA Inc. | ANDA | Current |
| 69097-277 | Valganciclovir | Valganciclovir | Cipla USA Inc. | ANDA | Current |
| 69097-277 | Valganciclovir | Valganciclovir | Cipla USA Inc. | ANDA | Current |
| 69097-277 | Valganciclovir | Valganciclovir | Cipla USA Inc. | ANDA | Current |